Barbier, M.A.; Ferland, K.; De Koninck, H.; Doucet, E.J.; Dubourget, L.; Kim, M.; Cattier, B.; Morissette, A.; Bchetnia, M.; Larouche, D.;
et al. Cancer Spheroids Embedded in Tissue-Engineered Skin Substitutes: A New Method to Study Tumorigenicity In Vivo. Int. J. Mol. Sci. 2024, 25, 1513.
https://doi.org/10.3390/ijms25031513
AMA Style
Barbier MA, Ferland K, De Koninck H, Doucet EJ, Dubourget L, Kim M, Cattier B, Morissette A, Bchetnia M, Larouche D,
et al. Cancer Spheroids Embedded in Tissue-Engineered Skin Substitutes: A New Method to Study Tumorigenicity In Vivo. International Journal of Molecular Sciences. 2024; 25(3):1513.
https://doi.org/10.3390/ijms25031513
Chicago/Turabian Style
Barbier, Martin A., Karel Ferland, Henri De Koninck, Emilie J. Doucet, Ludivine Dubourget, MinJoon Kim, Bettina Cattier, Amélie Morissette, Mbarka Bchetnia, Danielle Larouche,
and et al. 2024. "Cancer Spheroids Embedded in Tissue-Engineered Skin Substitutes: A New Method to Study Tumorigenicity In Vivo" International Journal of Molecular Sciences 25, no. 3: 1513.
https://doi.org/10.3390/ijms25031513
APA Style
Barbier, M. A., Ferland, K., De Koninck, H., Doucet, E. J., Dubourget, L., Kim, M., Cattier, B., Morissette, A., Bchetnia, M., Larouche, D., Kim, D. H., St-Jean, G., & Germain, L.
(2024). Cancer Spheroids Embedded in Tissue-Engineered Skin Substitutes: A New Method to Study Tumorigenicity In Vivo. International Journal of Molecular Sciences, 25(3), 1513.
https://doi.org/10.3390/ijms25031513
